Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T13:26:38.155Z.
Calculation as of: 2026-10-06T13:26:38.155Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea8f5c362e28cab1379660d94c14b865908cd29a247cab29e6d5b71901c6c862
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2016-11-03.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$766.41M
EV/EBIT Ratio
N/A
TTM Avg
877.08x
3Y Avg
871.89x
5Y Avg
871.89x
Market Cap
$786.48M
EV/EBIT Ratio
N/A
TTM Avg
501.20x
3Y Avg
422.57x
5Y Avg
422.57x
Market Cap
$737.02M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $776.24M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.54M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | N/A | 13.71x | 14.97x | 19.98x |
| Avalo Therapeutics, Inc. (AVTX)vs › | $766.41M | N/A | 877.08x | 871.89x | 871.89x |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | N/A | 501.20x | 422.57x | 422.57x |
| Candel Therapeutics, Inc. (CADL)vs › | $756.15M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $812.20M | 6.08x | 7.17x | 8.31x | 13.83x |
| Anteris Technologies Global Corp. (AVR)vs › | $737.02M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | N/A | 103.45x | 72.64x | 72.64x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2016-11-03 | 720.59x |
| 2016-11-02 | 736.98x |
| 2016-11-01 | 769.77x |
| 2016-10-31 | 736.98x |
| 2016-10-28 | 782.06x |
| 2016-10-27 | 802.55x |
| 2016-10-26 | 823.04x |
| 2016-10-25 | 827.14x |
| 2016-10-24 | 855.82x |
| 2016-10-21 | 847.63x |
| 2016-10-20 | 835.33x |
| 2016-10-19 | 831.23x |
| 2016-10-18 | 855.82x |
| 2016-10-17 | 831.23x |
| 2016-10-14 | 876.31x |
| 2016-10-13 | 884.51x |
| 2016-10-12 | 884.51x |
| 2016-10-11 | 945.98x |
| 2016-10-10 | 962.37x |
| 2016-10-07 | 917.29x |
| 2016-10-06 | 950.07x |
| 2016-10-05 | 917.29x |
| 2016-10-04 | 909.09x |
| 2016-10-03 | 917.29x |
| 2016-09-30 | 905.00x |
| 2016-09-29 | 880.41x |
| 2016-09-28 | 909.09x |
| 2016-09-27 | 905.00x |
| 2016-09-26 | 884.51x |
| 2016-09-23 | 880.41x |
| 2016-09-22 | 888.60x |
| 2016-09-21 | 900.90x |
| 2016-09-20 | 818.94x |
| 2016-09-19 | 798.45x |
| 2016-09-16 | 749.28x |
| 2016-09-15 | 786.16x |
| 2016-09-14 | 827.14x |
| 2016-09-13 | 868.12x |
| 2016-09-12 | 921.39x |
| 2016-09-09 | 1150.87x |
| 2016-09-08 | 1228.73x |
| 2016-09-07 | 1228.73x |
| 2016-09-06 | 1216.44x |
| 2016-09-02 | 1105.79x |
| 2016-09-01 | 1097.60x |
| 2016-08-31 | 1081.21x |
| 2016-08-30 | 1081.21x |
| 2016-08-29 | 1068.91x |
| 2016-08-26 | 1085.30x |
| 2016-08-25 | 1073.01x |
| 2016-08-24 | 1064.81x |
| 2016-08-23 | 1097.60x |
| 2016-08-22 | 1101.70x |
| 2016-08-19 | 1093.50x |
| 2016-08-18 | 1097.60x |
| 2016-08-17 | 1097.60x |
| 2016-08-16 | 1101.70x |
| 2016-08-15 | 1154.97x |
| 2016-08-12 | 1101.70x |
| 2016-08-11 | 1085.30x |
| 2016-08-10 | 1064.81x |
| 2016-08-09 | 1097.60x |
| 2016-08-08 | 1093.50x |
| 2016-08-05 | 1109.89x |
| 2016-08-04 | 1089.40x |
